MedPath

APO-LENALIDOMIDE

APO-LENALIDOMIDE

Approved
DIN Number

02507978

Drug Class

Human

Market Date

Sep 1, 2021

Company
HC

Apotex Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02507978
AIG Number0152422005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L04AX04 LENALIDOMIDE
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

LENALIDOMIDEActive
Strength: 20 MG
Monograph: LENALIDOMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.